I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022We expect tofinish theMino-Loktrial this yearNot manycompaniesthis size with2 late stageassetsHemorrhoidsis a $2BmarketI won't diluteshareholdersWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacyWe willhaveexclusivityI/ONTAKis our leadassetMino-Lokis our leadassetThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokpotentialmarket>$1BMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Our Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateInsidersinvested$26.5mI/ONTAKwas thebest deal Iever madeI'm ashareholdermyselfWe will openupinternationalsites forMino-Lok trialMino-WrapOnly biotechwith 2 Myron'son theleadershipteamI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We intendto submita BLA in2H 2022We expect tofinish theMino-Loktrial this yearNot manycompaniesthis size with2 late stageassetsHemorrhoidsis a $2BmarketI won't diluteshareholdersWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacyWe willhaveexclusivityI/ONTAKis our leadassetMino-Lokis our leadassetThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokpotentialmarket>$1BMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Our Halo-Lido trial willhave finalpatient byend of 2022An actualiMSCupdateInsidersinvested$26.5mI/ONTAKwas thebest deal Iever madeI'm ashareholdermyselfWe will openupinternationalsites forMino-Lok trialMino-WrapOnly biotechwith 2 Myron'son theleadershipteam

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  2. We intend to submit a BLA in 2H 2022
  3. We expect to finish the Mino-Lok trial this year
  4. Not many companies this size with 2 late stage assets
  5. Hemorrhoids is a $2B market
  6. I won't dilute shareholders
  7. We have enough cash to go well into 2023
  8. I/ONTAK's potential market is >$300m
  9. We had a phase 2b trial with 100% efficacy
  10. We will have exclusivity
  11. I/ONTAK is our lead asset
  12. Mino-Lok is our lead asset
  13. There are no FDA approved drugs to treat hemorrhoids
  14. Mino-Lok potential market >$1B
  15. Myron Holubiak and I founded a private company in 2013
  16. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  17. Our Halo-Lido trial will have final patient by end of 2022
  18. An actual iMSC update
  19. Insiders invested $26.5m
  20. I/ONTAK was the best deal I ever made
  21. I'm a shareholder myself
  22. We will open up international sites for Mino-Lok trial
  23. Mino-Wrap
  24. Only biotech with 2 Myron's on the leadership team